Dr. Michael Atkins, Georgetown-Lombardi Comprehensive Cancer Center, details the positive trial results for immunotherapy in a wide variety of cancers. He also describes current trials of combination regimens and the future of immunotherapy.
Dr. Michael Atkins, Georgetown-Lombardi Comprehensive Cancer Center, details the positive trial results for immunotherapy in a wide variety of cancers. He also describes current trials of combination regimens and the future of immunotherapy.
leggi di più
leggi meno
7 anni fa
#atkins, #cancer, #cancergrace, #center, #checkpoint, #combination, #comprehensive, #durable, #georgetownlombardi, #grace, #gracecast, #immune, #immunotherapy, #ipilimumab, #michael, #nivolumab, #pd1, #pdl1, #pembrolizumab, #response
